Cytomegalovirus retinitis and the acquired immunodeficiency syndrome-bench to bedside: LXVII Edward Jackson memorial lecture

American Journal of Ophthalmology

Volumn 151, Issue 2, 2011, Pages

  Jabs, Douglas A ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS MONOCLONAL ANTIBODY; FOMIVIRSEN; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; HLA ANTIGEN CLASS 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VALGANCICLOVIR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTEREMIA; CATARACT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS RETINITIS; DRUG EFFICACY; GENETIC SUSCEPTIBILITY; HEALTH CARE ACCESS; HEREDITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RECOVERY UVEITIS; IMMUNE SYSTEM; IMPLANT; LONGITUDINAL STUDY; MAINTENANCE THERAPY; MEDICAL LITERATURE; MONOTHERAPY; MORTALITY; MYCOBACTERIUM AVIUM; NATURAL KILLER CELL; PATHOGENESIS; PHACOEMULSIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA DETACHMENT; RETINA MACULA EDEMA; RETINA NECROSIS; RETINOPATHY; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SURVIVAL; SYSTEMIC THERAPY; TH1 CELL; TREATMENT OUTCOME; UVEITIS; VIRUS GENE; VIRUS LOAD; VIRUS REACTIVATION; VIRUS RESISTANCE; VISUAL IMPAIRMENT;

EID: 78751643169     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2010.10.018     Document Type: Article

References (140)

1. M. Fiala, S.N. Chatterjee, and S. Carson Cytomegalovirus retinitis secondary to chronic viremia in phagocytic leukocytes Am J Ophthalmol 84 4 1977 567 573
2. M. Fiala, J.E. Payne, and T.V. Berne Epidemiology of cytomegalovirus infection after transplantation and immunosuppression J Infect Dis 132 4 1975 421 433
3. N.M. Coskuncan, D.A. Jabs, and J.P. Dunn The eye in bone marrow transplantation: VI. Retinal complications Arch Ophthalmol 112 3 1994 1372 1379
4. I.C. Kuo, J.H. Kempen, J.P. Dunn, G. Vogelsang, and D.A. Jabs Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection Am J Ophthalmol 138 3 2004 338 346
5. D.A. Jabs Ocular manifestations of HIV infection Trans Am Ophthalmol Soc 93 1995 623 683
6. J.E. Gallant, R.D. Moore, D.D. Richman, J. Keruly, and R.E. Chaisson Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine The Zidovudine Epidemiology Study Group J Infect Dis 166 6 1992 1223 1227
7. P. Pertel, R.E. Hirschtick, J. Phair, J.S. Chmiel, L. Poggensee, and R. Murphy Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus J Acquir Immune Defic Syndr 5 11 1992 1069 1074
8. D.R. Hoover, Y. Peng, and A. Saah Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression Arch Ophthalmol 114 7 1996 821 827
9. M.L. Tay-Kearney, C. Enger, R.D. Semba, W. Royal III, J.P. Dunn, and D.A. Jabs T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients J Infect Dis 176 3 1997 790 794
10. G.N. Holland, J.D. Vaudaux, and S.M. Jeng Characteristics of untreated AIDS-related cytomegalovirus retinitis I. Findings before the era of highly active antiretroviral therapy (1988-1994) Am J Ophthalmol 145 1 2008 5 11
11. D.R. Hoover, M.H. Neil, and H.B. Graham An epidemiologic analysis of Mycobacterium avium complex disease in homosexual men infected with human immunodeficiency virus type 1 Clin Infect Dis 20 1995 1250 1258
12. F.J. Palella Jr, K.M. Delaney, and A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators N Engl J Med 338 13 1998 853 860
13. C.D. Holtzer, M.A. Jacobson, and W.K. Hadley Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994-1997 AIDS 12 14 1998 1931 1933
14. M.A. Jacobson, H. Stanley, C. Holtzer, T.P. Margolis, and E.T. Cunningham Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy Clin Infect Dis 30 1 2000 231 233
15. D.A. Jabs, M.L. Van Natta, J.T. Holbrook, J.H. Kempen, C.L. Meinert, M.D. Davis Studies of the Ocular Complications of AIDS Research Group Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment 1 Ophthalmology 114 4 2007 780 786
16. D.A. Jabs AIDS and ophthalmology, 2008 Arch Ophthalmol 126 8 2008 1143 1146
17. R.S. Braithwaite, M.S. Roberts, and C.C. Chang Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: a decision model Ann Intern Med 148 3 2008 178 185
18. Late HIV testing - 34 states, 1996-2005 MMWR Morb Mortal Wkly Rep 58 24 2009 661 665
19. P.D. Griffiths, and M.A. Polis Cytomegalovirus disease R. Dolin, H. Masur, M. Saag, AIDS Therapy 3rd ed. 2008 Elsevier Philadelphia 855 884
20. B.B. Wentworth, and E.R. Alexander Seroepidemiology of infections due to members of the herpesvirus group Am J Epidemiol 94 5 1971 496 507
21. W.L. Drew, L. Mintz, and R.C. Miner Prevalence of cytomegalovirus infection in homosexual men J Infect Dis 143 2 1981 188 192
22. D.A. Jabs, C. Enger, J.P. Dunn, M. Forman, L. Hubbard Cytomegalovirus Retinitis and Viral Resistance Research Group Cytomegalovirus retinitis and viral resistance: 3. Culture results Am J Ophthalmol 126 4 1998 543 549 (Pubitemid 28475918)
23. D.A. Jabs, B.K. Martin, M.S. Forman, M.O. Ricks Cytomegalovirus Retinitis and Viral Resistance Research Group Cytomegalovirus (CMV) blood DNA load, CMV retinitis progression, and occurrence of resistant CMV in patients with CMV retinitis J Infect Dis 192 4 2005 640 649
24. N.A. Rao, J. Zhang, and S. Ishimoto Role of retinal vascular endothelial cells in development of CMV retinitis Trans Am Ophthalmol Soc 96 1998 111 123 discussion 124126
25. J.S. Pepose, G.N. Holland, M.S. Nestor, A.J. Cochran, and R.Y. Foos Acquired immune deficiency syndrome Pathogenic mechanisms of ocular disease Ophthalmology 92 4 1985 472 484
26. M.G. Davis, S.C. Kenney, J. Kamine, J.S. Pagano, and E.S. Huang Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus Proc Natl Acad Sci U S A 84 23 1987 8642 8646
27. P.R. Skolnik, B.R. Kosloff, and M.S. Hirsch Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus J Infect Dis 157 3 1988 508 514
28. P.R. Skolnik, R.J. Pomerantz, and S.M. de la Monte Dual infection of retina with human immunodeficiency virus type 1 and cytomegalovirus Am J Ophthalmol 107 1989 261 272
29. S.V. Kotenko, S. Saccani, L.S. Izotova, O.V. Mirochnitchenko, and S. Pestka Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) Proc Natl Acad Sci U S A 97 4 2000 1695 1700
30. J.V. Spencer, K.M. Lockridge, and P.A. Barry Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 J Virol 76 3 2002 1285 1292
31. H.F. Seow Pathogen interactions with cytokines and host defence: an overview Vet Immunol Immunopathol 63 12 1998 139 148
32. C. Vink, P.S. Beisser, and C.A. Bruggeman Molecular mimicry by cytomegaloviruses Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines Intervirology 42 56 1999 342 349
33. A. Kovacs, M. Schluchter, and K. Easley Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group N Engl J Med 341 2 1999 77 84
34. A. Webster, C.A. Lee, and D.G. Cook Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection Lancet 2 8654 1989 63 66
35. C.A. Sabin, A.N. Phillips, C.A. Lee, G. Janossy, V. Emery, and P.D. Griffiths The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversion Epidemiol Infect 114 2 1995 361 372
36. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4. Visual outcomes Ophthalmology 101 7 1994 1250 1261
37. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS The Cytomegalovirus Retreatment Trial Arch Ophthalmol 114 1 1996 23 33
38. Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial Arch Ophthalmol 115 12 1997 1528 1536
39. J.T. Holbrook, D.A. Jabs, D.V. Weinberg, R.A. Lewis, M.D. Davis, D. Friedberg Studies of Ocular Complications of AIDS Research Group Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy Arch Ophthalmol 121 1 2003 99 107
40. J.E. Thorne, D.A. Jabs, J.H. Kempen, J.T. Holbrook, C. Nichols, C.L. Meinert Studies of Ocular Complications of AIDS Research Group Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy Ophthalmology 113 8 2006 1432 1440 (Pubitemid 44108166)
41. J.E. Thorne, D.A. Jabs, J.H. Kempen, J.T. Holbrook, C. Nichols, C.L. Meinert Studies of Ocular Complications of AIDS Research Group Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy Ophthalmology 113 8 2006 1441 1445 (Pubitemid 44108167)
42. E.L. Murphy, A.C. Collier, and L.A. Kalish Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease Ann Intern Med 135 1 2001 17 26
43. K.V. Komanduri, M.N. Viswathanan, and E.D. Wieder Restoration of cytomegalovirus specific CD4+ T lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1 Nat Med 4 8 1998 953 956
44. S.C. Johnson, C.A. Benson, D.W. Johnson, and A. Weinberg Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution Clin Infect Dis 32 5 2001 815 819
45. K.V. Komanduri, J. Feinberg, and R.K. Hutchins Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis J Infect Dis 183 8 2001 1285 1289
46. D.A. Jabs, S.G. Bolton, J.P. Dunn, and A.G. Palestine Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy Am J Ophthalmol 126 6 1998 817 822
47. J.C. Macdonald, F.J. Torriani, L.S. Morse, M.P. Karavellas, J.B. Reed, and W.R. Freeman Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy J Infect Dis 177 5 1998 1182 1187
48. S.M. Whitcup, E. Fortin, and A.S. Lindblad Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis JAMA 282 17 1999 1633 1637
49. O. Kirk, P. Reiss, and C. Uberti-Foppa Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy Ann Intern Med 137 4 2002 239 250
50. F.J. Torriani, W.R. Freeman, and J.C. Macdonald CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy AIDS 14 2 2000 173 180
51. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents MMWR Morb Mortal Wkly Rep 58 RR-4 2009 55
52. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis Am J Ophthalmology 124 2 1997 141 157
53. D.A. Jabs, M.L. Van Natta, J.T. Holbrook, J.H. Kempen, C.L. Meinert, M.D. Davis Studies of Ocular Complications of AIDS Research Group Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment Ophthalmology 114 4 2007 787 793 (Pubitemid 46483694)
54. Q.D. Nguyen, J.H. Kempen, S.G. Bolton, J.P. Dunn, and D.A. Jabs Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy Am J Ophthalmol 129 5 2000 634 639
55. M.R. Robinson, G. Reed, K.G. Csaky, M.A. Polis, and S.M. Whitcup Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy Am J Ophthalmol 130 1 2000 49 56
56. M.P. Karavellas, D.J. Plummer, and J.C. Macdonald Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy J Infect Dis 179 3 1999 697 700
57. J.H. Kempen, Y.I. Min, W.R. Freeman Studies of Ocular Complications of AIDS Research Group Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis Ophthalmology 113 4 2006 684 694
58. I. Taskintuna, F.M. Rahhal, and J.F. Arevalo Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome Ophthalmology 104 6 1997 1049 1057 (Pubitemid 27255419)
59. R.B. Nussenblatt, and H.C. Lane Human immunodeficiency virus disease: changing patterns of intraocular inflammation Am J Ophthalmol 125 3 1998 374 382
60. D.A. Jabs, A. Ahuja, M. VanNatta, A. Lyon, S. Srivastava, S. Gangaputra Studies of the Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: Five-year outcomes Ophthalmology 117 11 2010 2152 2161
61. G. Ortega-Larrocea, E. Espinosa, and G. Reyes-Teran Lower incidence and severity of cytomegalovirus-associated immune recovery uveitis in HIV-infected patients with delayed highly active antiretroviral therapy AIDS 19 7 2005 735 738
62. A. Zolopa, J. Anderson, and W. Powderly Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial PLoS One 4 5 2009 e5575
63. A.G. Palestine, M.A. Polis, and M.D. De Smet A randomized, controlled trial of Foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS Ann Intern Med 115 9 1991 665 673
64. S.A. Spector, T. Weingeist, and R.B. Pollard A randomized controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS J Infect Dis 168 3 1993 557 563
65. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis N Engl J Med 326 4 1992 213 220
66. Studies of Ocular Complications of AIDS Research Group, in Collaboration with the AIDS Clinical Trials Group Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: The HPMPC Peripheral Cytomegalovirus Retinitis Trial Ann Intern Med 126 4 1997 264 274
67. J.P. Lalezari, R.J. Stagg, and B.D. Kuppermann Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS: A randomized, controlled trial Ann Intern Med 126 4 1997 257 263
68. D.F. Martin, D.J. Parks, and S.D. Mellow Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant A randomized controlled clinical trial Arch Ophthalmol 112 12 1994 1531 1539
69. D.C. Musch, D.F. Martin, J.F. Gordon, M.D. Davis, and B.D. Kuppermann Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant The Ganciclovir Implant Study Group N Engl J Med 337 2 1997 83 90
70. D.F. Martin, B.D. Kuppermann, R.A. Wolitz, A.G. Palestine, H. Li, and C.A. Robinson Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant Roche Ganciclovir Study Group N Engl J Med 340 14 1999 1063 1070
71. The Studies of Ocular Complications of AIDS Research Group The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial Am J Ophthalmol 131 4 2001 457 467
72. D.F. Martin, J. Sierra-Madero, and S. Walmsley A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis N Engl J Med 346 15 2002 1119 1126
73. Jabs DA. Clinical research in uveitis. In: Zierhut M, editor. Uveitis. New York: Springer Publishing Company. Forthcoming.
74. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 1. Rationale, design, and methods AIDS Clinical Trials Group (ACTG) Control Clin Trials 13 1 1992 22 39
75. J.T. Holbrook, C.L. Meinert, M.L. Van Natta, M. Davis, L. Hubbard, D.A. Jabs Studies of Ocular Complications of AIDS Research Group Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients Arch Ophthalmol 119 4 2001 554 563
76. L.D. Hubbard, M.O. Ricks, B.K. Martin Cytomegalovirus Retinitis and Viral Resistance Study Group Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression Am J Ophthalmol 137 3 2004 426 434
77. G.N. Holland, W.C. Buhles Jr, B.J. Mastre, H.J. Kaplan, and U.C.R.S. Group A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy: use of a standardized system for the assessment of disease outcome Arch Ophthalmol 107 12 1989 1759 1766
78. Studies of Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial AIDS 14 11 2000 1571 1581
79. D.F. Martin, F.L. Ferris, and D.J. Parks Ganciclovir implant exchange: timing, surgical procedure, and complications Arch Ophthalmol 115 11 1997 1389 1394
80. J.H. Kempen, D.A. Jabs, L.A. Wilson, J.P. Dunn, S.K. West, and J. Tonascia Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome Clin Infect Dis 37 10 2003 1365 1373 (Pubitemid 37433634)
81. M. Diaz-Llopis, E. Espaa, and G. Muoz High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS Br J Ophthalmol 78 2 1994 120 124
82. S. Young, N. Morlet, and G. Besen High-dose (2000-μg) intravitreous ganciclovir in the treatment of cytomegalovirus retinitis Ophthalmology 105 1998 1404 1410
83. L. Visser Managing CMV retinitis in the developing world Community Eye Health 16 47 2003 38 39
84. D.A. Jabs, M.L. Van Natta, J.E. Thorne Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. retinitis progresion Ophthalmology 111 12 2004 2224 2231 (Pubitemid 39585188)
85. D.A. Jabs, M.L. Van Natta, J.E. Thorne Studies of Ocular Complications of AIDS Research Group Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. second eye involvement and retinal detachment Ophthalmology 111 12 2004 2232 2239 (Pubitemid 39575593)
86. The Studies of Ocular Complications of AIDS (SOCA) Research Group, in Collaboration with the AIDS Clinical Trials Group (ACTG) Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial Am J Ophthalmol 124 1 1997 61 70
87. M.A. Jacobson, J.J. O'Donnell, H.R. Brodie, C. Wofsy, and J. Mills Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis J Med Virol 25 3 1988 339 349
88. B.D. Kuppermann, J.I. Quiceno, and M. Flores-Aguilar Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy J Infect Dis 168 6 1993 1506 1509
89. J.F. Arevalo, C. Gonzalez, and E.V. Capparelli Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus retinitis J Infect Dis 172 4 1995 951 956
90. D.A. Jabs, J.P. Dunn, C. Enger Cytomegalovirus Retinitis and Viral Resistance Study Group Cytomegalovirus retinitis and viral resistance: prevalence of resistance at diagnosis, 1994 Arch Ophthalmol 114 7 1996 809 814
91. W.L. Drew, and R.C. Miner Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection J Infect Dis 163 4 1991 716 719
92. D.A. Jabs, C. Enger, J.P. Dunn, M. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Cytomegalovirus retinitis and viral resistance: ganciclovir resistance CMV Retinitis and Viral Resistance Study Group J Infect Dis 177 3 1998 770 773
93. D.A. Jabs, C. Enger, M. Forman, J.P. Dunn Cytomegalovirus Retinitis and Viral Resistance Research Group Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis The Cytomegalovirus Retinitis and Viral Resistance Study Group Antimicrob Agents Chemother 42 9 1998 2240 2244
94. A. Weinberg, D.A. Jabs, S. Chou Cytomegalovirus Retinitis and Viral Resistance Research Group Mutations conferring foscarnet resistance in a cohort of patients with the acquired immunodeficiency syndrome and cytomegalovirus retinitis J Infect Dis 187 5 2003 777 784
95. D.A. Jabs, B.K. Martin, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis J Infect Dis 183 2 2001 333 337
96. D.A. Jabs, B.K. Martin, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8 Am J Ophthalmol 132 5 2001 700 710
97. S. Chou, G. Marousek, and S. Guentzel Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease J Infect Dis 176 3 1997 786 789
98. A. Erice, C. Gil-Roda, and J.L. Perez Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients J Infect Dis 175 5 1997 1087 1092
99. S. Chou, N.S. Lurain, A. Weinberg, G.Y. Cai, P.L. Sharma, and C.S. Crumpacker Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance Adult AIDS Clinical Trials Group CMV Laboratories Antimicrob Agents Chemother 43 6 1999 1500 1502
100. N.S. Lurain, A. Weinberg, C.S. Crumpacker, and S. Chou Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistance testing Antimicrob Agents Chemother 45 10 2001 2775 2780
101. S. Chou, R.H. Waldemer, and A.E. Senters Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir J Infect Dis 185 2 2002 162 169
102. A. Erice Resistance of human cytomegalovirus to antiviral drugs Clin Microbiol Rev 12 2 1999 286 297
103. S. Chou, N.S. Lurain, K.D. Thompson, R.C. Miner, and W.L. Drew Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus J Infect Dis 188 1 2003 32 39
104. I.L. Smith, J.M. Cherrington, R.E. Jiles, M.D. Fuller, W.R. Freeman, and S.A. Spector High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes J Infect Dis 176 1 1997 69 77
105. S.A. Spector, K. Hsia, D. Wolf, M. Shinkai, and I. Smith Molecular detection of human cytomegalovirus and determination of genotypic ganciclovir resistance in clinical specimens Clin Infect Dis 21 Suppl 2 1995 S170 S173
106. G. Gerna, A. Sarasini, E. Percivalle, M. Zavattoni, F. Baldanti, and M.G. Revello Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples J Clin Microbiol 33 3 1995 738 741
107. J.P. Dunn, M.W. MacCumber, M.S. Forman, P. Charache, L. Apuzzo, and D.A. Jabs Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir Am J Ophthalmol 119 5 1995 587 596
108. C. Enger, D.A. Jabs, J.P. Dunn Cytomegalovirus Retinitis and Viral Resistance Research Group Viral resistance and CMV retinitis: design and methods of a prospective study CRVR Research Groups. Cytomegalovirus Retinitis Viral Resistance Research Group Ophthalmic Epidemiol 4 1 1997 41 48
109. H. Hu, D.A. Jabs, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Comparison of cytomegalovirus (CMV) UL97 gene sequences in the blood and vitreous of patients with acquired immunodeficiency syndrome and CMV retinitis J Infect Dis 185 7 2002 861 867
110. D.A. Jabs, B.K. Martin, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis Am J Ophthalmol 135 1 2003 26 34
111. D.A. Jabs, B.K. Martin, M.O. Ricks, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Detection of ganciclovir resistance in patients with AIDS and cytomegalovirus retinitis: correlation of genotypic methods with viral phenotype and clinical outcome J Infect Dis 193 12 2006 1728 1737
112. B.K. Martin, M.O. Ricks, M.S. Forman, D.A. Jabs Cytomegalovirus Retinitis and Viral Resistance Research Group Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis Clin Infect Dis 44 7 2007 1001 1008
113. J.I. Lim, C. Enger, and J.A. Haller Improved visual results after surgical repair of cytomegalovirus-related retinal detachments Ophthalmology 101 2 1994 264 269
114. A.P. Tanna, J.H. Kempen, J.P. Dunn, J.A. Haller, and D.A. Jabs Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis Am J Ophthalmol 136 6 2003 1009 1015
115. D. Mitry, D.G. Charteris, B.W. Fleck, H. Campbell, and J. Singh The epidemiology of rhegmatogenous retinal detachment: geographical variation and clinical associations Br J Ophthalmol 94 6 2010 678 684
116. D.A. Jabs, J.T. Holbrook, M.L. Van Natta Studies of the Ocular Complications of AIDS Research Group Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy Ophthalmology 112 5 2005 771 779
117. Studies of the Ocular Complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group Antiviral effects of foscarnet and ganciclovir therapy on human immunodeficiency virus p24 antigen in patients with AIDS and cytomegalovirus retinitis J Infect Dis 172 3 1995 613 621
118. D.A. Jabs, B.K. Martin, M.S. Forman Cytomegalovirus Retinitis and Viral Resistance Research Group Mortality associated with resistant cytomegalovirus among patients with cytomegalovirus retinitis and AIDS Ophthalmology 117 1 2010 128 132
119. S.J. O'Brien, and J.P. Moore The effect of genetic variation in chemokines and their receptors on HIV transmission and progression to AIDS Immunol Rev 177 2000 99 111
120. S.J. O'Brien, and G.W. Nelson Human genes that limit AIDS Nat Genet 36 6 2004 565 574
121. S.L. Hendrickson, L.P. Jacobson, and G.W. Nelson Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival J Acquir Immune Defic Syndr 48 3 2008 263 271
122. E. Sezgin, D.A. Jabs, S.L. Hendrickson Studies of the Ocular Complications of AIDS Research Group Effect of host genetics on cytomegalovirus retinitis occurrence in patients with AIDS J Infect Dis 202 4 2010 606 613
123. C. Gasche, P. Grundtner, and P. Zwirn Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production J Immunol 170 11 2003 5578 5582
124. S.G. Gruber, M. Gloria Luciani, P. Grundtner, A. Zdanov, and C. Gasche Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1 Eur J Immunol 38 12 2008 3365 3375
125. D.G. Brooks, M.J. Trifilo, K.H. Edelmann, L. Teyton, D.B. McGavern, and M.B. Oldstone Interleukin-10 determines viral clearance or persistence in vivo Nat Med 12 11 2006 1301 1309
126. M. Ejrnaes, C.M. Filippi, and M.M. Martinic Resolution of a chronic viral infection after interleukin-10 receptor blockade J Exp Med 203 11 2006 2461 2472
127. D.A. Jabs, M.L. Van Natta, and J.H. Kempen Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy Am J Ophthalmol 133 1 2002 48 61
128. G.N. Holland, and J.D.Shiramizu Vaudaux Characteristics of untreated AIDS-related cytomegalovirus retinitis II. Findings in the era of highly active antiretroviral therapy (1997 to 2000) Am J Ophthalmol 145 1 2008 12 22
129. J.H. Kempen, D.A. Jabs, and L.A. Wilson Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome Arch Ophthalmol 121 4 2003 466 476
130. D. Heiden, N. Ford, and D. Wilson Cytomegalovirus retinitis: The neglected disease of the AIDS pandemic PLoS Med 4 12 2007 e334
131. P. Kestelyn The epidemiology of CMV retinitis in Africa Ocul Immunol Inflamm 7 1999 173 177
132. Y. El Mansouri, K. Zaghoul, H. Himmich, and A. Amraoui Les atteintes oculaires au cours de l'infection par le VIH au CHU de Casablanca A propos de 400 cas Bull Soc Pathol Expt 93 1 2000 14 16
133. A.T. Giorgis, F. Melka, and A.G. Mariam Ophthalmic manifestations of AIDS in Armed Forces General Teaching Hospital, Addis Ababa Ethiop Med J 45 4 2007 327 333
134. C. Ebana Mvogo, A. Ellong, A.L. Bella, H. Luma, and H. Achu Joko Complications oculaires de l'infection a VIH-SIDA en milieu Camerounais: Y a-t-il une corrlation avec le taux de CD4? Bull Soc Belge Ophtalmol 305 2007 7 12
135. S.N. Nwosu HIV/AIDS in ophthalmic patients: The Guiness Eye Centre Onitsha experience Niger Postgrad Med J 15 1 2008 24 27
136. O. Nkomazand, and D. Tshitswana Ocular complications of HIV infection in Sub-Saharan Africa Curr HIV/AIDS Rep 5 3 2008 120 125
137. K.-P. Balo, Y.-P. Amoussou, and A. Bchetoille Rtinites cytomgalovirus et complications oculaires du SIDA au Togo J Fr Ophtalmol 22 10 1999 1042 1046
138. J. Otitti-Sengeri, R. Colebunders, J.H. Kempen, A. Ronald, M. Sande, and E. Katabira The prevalence and causes of visual loss among HIV-infected individuals in Uganda J Acquir Immune Defic Syndr 53 1 2010 95 101
139. J. Biswas, H.N. Madhavan, A.E. George, N. Kumarasamy, and S. Solomon Ocular lesions associated with HIV infection in India: a series of 100 consecutive patients evaluated at a referral center Am J Ophthalmol 129 1 2000 9 15
140. K. Pathanapitoon, S. Ausayakhun, and P. Kunavisarut Blindness and low vision in a tertiary ophthalmologic center in Thailand: The importance of cytomegalovirus retinitis Retina 27 5 2007 635 640